【摘 要】
：
Background Anticoagulant therapy with rivaroxaban in patient after radiofrequency catheter ablation (RFCA) has been reported in limited numbers of patients.This study evaluated the effectiaveness and
【机 构】
：
Department of Cardiology,Institute of Cardiovascular Research of People's Liberation Army,Shenyang
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
论文部分内容阅读
Background Anticoagulant therapy with rivaroxaban in patient after radiofrequency catheter ablation (RFCA) has been reported in limited numbers of patients.This study evaluated the effectiaveness and safety of anticoagulant therapy with these patients.Methods A cohort of 157 patients who underwent RFCA of AF wad enrolled.The 150 patients were divided into rivaroxaban group (57 patients) and warfarin group (100 patients).In rivaroxaban group,rivaroxaban 10 mg,bid or 20 mg,QD was given for 1 month,and then 20 mg daily or 10 mg daily for 1 more month according to the patients CHADS2 scores.In warfarin group,standard medication of warfarin was given for 2 months by adjusting the INR in the range between 2.0 and 3.0.All the patients took the same anticoagulant during the whole period of anticoagulation therapy.
其他文献
Background Growing evidence shows that microRNAs (miRNAs) are involved in various cardiac processes including cardiomyocyte apoptosis.However,the modulation of miRNA by pharmacological intervention in
Background The aim of this study was to evaluate the role of β2 adrenergic receptor (β2-AR) on ventricular arrhythmia (VA) in heart failure (HF) models of guinea pigs,and investigate the pathways of G
Background The beneficial effects of stem cell hypoxic preconditioning (HPC) prior to treatment of acute myocardial infarction (AMI) have been confirmed in multiple studies that describe enhanced cell
Background Peripheral artery disease (PAD) has a poor prognosis and remains a leading cause of disability.Recently,mesenchymal stem cells (MSCs) transplantation shows promise for functional improvemen
Background Cell therapy is a promising approach for acute myocardial infarction (AMI) and heart failure.With unique access to the ischemic myocardium,retrograde coronary venous delivery has been demon
Background The aim of this study was to investigate the effect and mechanism of bone marrow mesenchymal stem cells (BMSCs) on the electrophysiological characteristics of hypertrophic cardiomyocytes an
Background The aim of the study is to investigate the effect of magnetic targeting intensities on cell transplantation,we used different magnetic targeting intensities for mesenchymal stem cells thera
Background The aim of the study is to explore the mechanisms of protective effects ofDiazoxide,a mitoKATP opener (KCO),on mitochondrial functions in hypoxic ischemic myocardial damage model induced by
Background The aim of this study was to investigate whether rosuvastatin improved survival of adipose-derived mesenchymal stem cells (AD-MSCs) after transplantation into infarcted hearts.Methods AD-MS
Background Catheter ablation of focal atrial tachycardia (FAT) arising in anterior septum (AS) and nearby region has been reported in limited numbers of patients.This study investigated the electrocar